
    
      The main goal of this PROOF study is to evaluate, on a selected prospective cohort of
      subjects aged 65 years upon study entry, the prognostic values of ANS activity levels
      measured at preset times, and more specifically, of its decline over the follow-up period,
      for fatal and non-fatal cardiovascular and cerebrovascular events.
    
  